Oculus Innovative Sciences to Collaborate with Onset Therapeutics
Their initial collaboration will target atopic dermatitis and related conditions.
Their initial collaboration will target atopic dermatitis and related conditions.
Patients with psoriasis demonstrated 79% improvement in the Psoriasis Scoring Index after four weeks of daily treatment with PH-10.
Copyright © 2024 | WordPress Theme by MH Themes